INFLUENCE OF PPARG2 POLYMORPHISM IN THE PRO12Ala GENE ON THE RISK OF PURULENT-NECROTIC DAMAGE TO THE LEGS IN PATIENTS WITH TYPE 2 DIABETES

This study was conducted on patients undergoing inpatient treatment at the clinical bases of the Andijan State Medical Institute. To implement the goals and objectives of our scientific research, a total of 201 people were involved in the research. Molecular genetic studies were conducted at the Republican Specialized Scientific and Practical Medical Center of Hematology of the Ministry of Health of the Republic of Uzbekistan. It can be seen that the Pro12Ala polymorphism of the PPARG2 gene has a statistically significant tendency to cause purulent-necrotic diseases of the lower extremities in the group of patients with diabetes mellitus, i.e., the probability of developing these pathologies is 4.9 times higher in patients with the unfavorable Ala/Ala genotype (χ2=2.5; OR=4.9; 95%CI:0.69-35.25). Statistical processing of the results was carried out using the standard OpenEpi V.9.2. software package.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-02-27
DOI
https://doi.org/10.5281/zenodo.14940163
Primary Topic
Peroxisome Proliferator-Activated Receptors
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

INFLUENCE OF PPARG2 POLYMORPHISM IN THE PRO12Ala GENE ON THE RISK OF PURULENT-NECROTIC DAMAGE TO THE LEGS IN PATIENTS WITH TYPE 2 DIABETES

Zenodo (CERN European Organization for Nuclear Research)
Peroxisome Proliferator-Activated Receptors
article

INFLUENCE OF PPARG2 POLYMORPHISM IN THE PRO12Ala GENE ON THE RISK OF PURULENT-NECROTIC DAMAGE TO THE LEGS IN PATIENTS WITH TYPE 2 DIABETES

article en

Abstract

This study was conducted on patients undergoing inpatient treatment at the clinical bases of the Andijan State Medical Institute. To implement the goals and objectives of our scientific research, a total of 201 people were involved in the research. Molecular genetic studies were conducted at the Republican Specialized Scientific and Practical Medical Center of Hematology of the Ministry of Health of the Republic of Uzbekistan. It can be seen that the Pro12Ala polymorphism of the PPARG2 gene has a statistically significant tendency to cause purulent-necrotic diseases of the lower extremities in the group of patients with diabetes mellitus, i.e., the probability of developing these pathologies is 4.9 times higher in patients with the unfavorable Ala/Ala genotype (χ2=2.5; OR=4.9; 95%CI:0.69-35.25). Statistical processing of the results was carried out using the standard OpenEpi V.9.2. software package.

Zenodo (CERN European Organization for Nuclear Research)
Partnerships for the goals, Good health and well-being
Openalex Percentile: Top 60%
Peroxisome Proliferator-Activated Receptors
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

INFLUENCE OF PPARG2 POLYMORPHISM IN THE PRO12Ala GENE ON THE RISK OF PURULENT-NECROTIC DAMAGE TO THE LEGS IN PATIENTS WITH TYPE 2 DIABETES · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS